Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Prediction of neuroleptic on-drug response in schizophrenic in-patients by EEG

Summary

The subjects were 34 acutely ill in-patients who met the RDC criteria of schizophrenic psychosis, and 4 EEGs were recorded from each patient before, 2 h and 24 h after oral intake of a single dose of 150 mg perazine, and on the 28th day of the neuroleptic treatment period. As a criterion of clinical response a decrease of at least 66% in the schizophrenia-specific sum score of the Brief Psychiatric Rating Scale on day 28 relative to the baseline value was decided upon. The EEGs were assessed using a newly developed procedure which takes into consideration 4 derivations simultaneously. As we tried to search out EEG variables with predictive value the statistical data analysis underlying our findings should largely by regarded as exploratory. Independent of day, responders (R) showed a tendency towards more low voltage desynchronized epochs (non-A stage) than non-responders (NR). Thus, R exhibited a higher degree of dynamic variability or a broader range of control of the spontaneous vigilance fluctuation (dynamic lability) than NR (dynamic rigidity). Furthermore, R and NR differed with respect to their time-dependent changes of non-A epoch frequencies before medication. While R showed a monotonous increase which is typical for normals, NR did not. Because of considerable inter-individual variability these group differences could not be used for individual prediction of the therapy response. By means of a qualitative data analysis R could be distinguished from NR with regard to various test dose-induced changes of the topographical distribution of absolute alpha power. All the group differentiating variables showed a time course of the same kind: R showed a prompt and ample deflection and the same recovery of baseline; NR, in contrast, showed no significant deflections at all. These findings are in line with the results concerning the dynamics of vigilance and certain claims of earlier authors according to which EEG changeability should be decisive for therapeutic outcome. The prediction power could be enhanced considerably by means of a classification procedure for qualitative data, which allows a combination of two variables. Allowing the three qualities increase, decrease and no change a combination of two variables rendered 32 = 9 possible answer patterns, the individual patient showing only one of these patterns, of course. A correct classification of 26 out of the 34 patients (76.5%) was achieved by 12 different 2-fold combinations of variables. Eventually, we tried to base an individual prediction upon a multitude of selected, clearly response predicting answer patterns. We were governed by the idea that a patient who shows the total number of the response predicting answer patterns, can be regarded as R with much higher probability than a patient who shows only half the number or even none of them.

This is a preview of subscription content, log in to check access.

References

  1. Abt K (1977) Quantifizierung und statistische Auswertung von Ordinalskalendaten in der Psychiatrie. Pharmacopsychiatry 10:193–200

  2. Bente D (1961) Elektroencephalographische Gesichtspunkte zur Klassifikation neuro- und thymoleptischer Pharmaka. Med Exp 5:337–346

  3. Bente D (1963) Elektroenzephalographie und psychiatrische Pharmakotherapie. In: Achelis JD, Ditfurth H v (eds) Anthropologische und naturwissenschaftlich-klinische Grundlagenprobleme der Pharmakopsychiatrie. G. Thieme, Stuttgart, pp 75–99

  4. Bente D (1964) Die Insuffizienz des Vigilitätstonus. Postdoctoral-Thesis, Erlangen

  5. Bente D (1965) Das Elektroenzephalogramm bei Psychosen: Befunde und Probleme. Hippokrates 36:817–823

  6. Bente D (1979) Vigilance and evaluation of psychotropic drug effects on EEG. Pharmacopsychiatry 12:137–147

  7. Bente D (1981) Möglichkeiten und Grenzen der Elektroenzephalographie in der geriatrisch-pharmakotherapeutischen Forschung. In: Platt D (ed) Funktionsstörungen des Gehirns im Alter. F. K. Schattauer, Stuttgart New York, pp 137–144

  8. Bente D (1984) Elektroenzephalographische Vigilanzbestimmungen: Methoden und Beispiele. Z EEG-EMG 15:173–179

  9. Borenstein P, Dabbah M (1961) Utilité du controle E.E.G. des drogues psychotropes. Sem Hôp 37:1589–1593

  10. Dasberg H, Robinson S (1971) Electroencephalographic variations following anti-psychotic drug treatment. Dis New Syst 32:472–478

  11. d'Elia G, Jacobson L, Knorring von L, Mattson B, Mjorndal T, Oreland L, Perris C, Rupp W (1977) Changes in psychopathology in relation to EEG variables and visual averaged evoked responses (VAEP) in schizophrenic patients treated with penfluridol or thiothixene. Acta Psychiatr Scand 55:309–318

  12. Etevenon P, Pidoux B, Rioux P, Peron-Magnan P, Verdeux G, Deniker P (1979) Intra- and interhemispheric EEG differences quantified by spectral analysis. Comparative study of two groups of schizophrenics and a control group. Acta Psychiatr Scand 60:57–68

  13. Etevenon P (1984) Intra- and inter-hemispheric changes in alpha intensities in EEGs of schizophrenic patients versus matched controls. Biol Psychol 19:245–256

  14. Feigenberg IM (1964) Comparative electroencephalographic characteristics of various clinical groups of schizophrenic patients. Zh Nevropatol Psikhiatr 64:567–574

  15. Gaebel W, Schley J, Müller-Oerlinghausen B (1986) Prediction of response to acute antipsychotic treatment with perazine: early plasma levels of parentdrug, metabolites, and prolactin. Naunyn-Schmiedeberg's Arch Pharmacol Suppl 332:R101/404

  16. Giannitrapani D, Kayton L (1974) Schizophrenia and EEG spectral analysis. EEG clin. Neurophysiol. 36:377–386

  17. Goldstein L, Stolzfus NW (1973) Psychoactive drug-induced changes of interhemispheric EEG amplitude relationships. Agent Actions 3/2:129–132

  18. Gruzelier J (1983) Left- and right-sided dysfunction in psychosis: implications for electroencephalographic measurement. In: Mendlewicz J, Praag HM van (eds) Advances in biological psychiatry, vol 13. Karger, Basel, pp 192–195

  19. Hassenstein B (1973) Biologische Kybernetik, 4. Aufl. Quelle & Meyer, Heidelberg

  20. Head H (1923) Vigilance a physiological state of the nervous system. Br J Psychol 14:26–147

  21. Helmchen H, Künkel H (1964) Der Einfluß von EEG-Verlaufsuntersuchungen unter psychiatrischer Pharmakotherapie auf die Prognostik von Psychosen. Arch Psychiatr Z Ges Neurol 205:1–18

  22. Igert C, Lairy GC (1962) Intérêt pronostique de l'EEG an cours de l'évolution des schizophrenes. EEG Clin Neurophysiol 14:183–190

  23. Itil T (1980) Computer-analyzed electroencephalogram to predict the therapeutic outcome in schizophrenia. In: Baxter C, Melnechuk T (eds) Perspectives in schizophrenia research. Raven, New York, pp 61–75

  24. Itil T, Keskiner A, Fink M (1966) Therapeutic studies in “therapy resistant” schizophrenic patients. Compr Psychiatry 7:488–493

  25. Itil T, Keskiner M, Holden JMC (1969) The use of LSD and Ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach) J Dis New Syst 30 (Suppl):93–103

  26. Itil T, Marasa J, Saletu B, Davis S, Mucciardi RN, Mucciardi AN (1975) Computerized EEG: predictor of outcome in schizophrenia. J Nerv Ment Dis 160:188–203

  27. Janzarik W (1959) Dynamische Grundkonstellationen in endogenen Psychosen. Springer, Berlin Göttingen Heidelberg

  28. Künkel H (1982) On some hypotheses underlying pharmacoelectroencephalography. In: Herrmann WM (ed) Electroencephalography in drug research. G. Fischer, Stuttgart, pp 1–16

  29. Laurian S, Le PK, Baumann P, Perey M, Gaillard J-M (1981) Relationship between levels of chlorpromazine and effects on EEG and evoked potentials in healthy volunteers. Pharmacopsychiatry 14:199–204

  30. Laurian S, Gaillard J-M, Le PK, Schöpf J (1983) Topographic aspects of EEG profile of some psychotropic drugs. In: Mendlewicz J, Praag HM van (eds) Advances in biological psychiatry, vol 13. Karger, Basel, pp 165–171

  31. Lienert G (1973) Verteilungsfreie Methoden in der Biostatistik, vol I. A. Hain, Meisenheim

  32. Matoušek M, Capone C, Okawa M (1981) Measurement of the interhemispheric differences as diagnostic tool in psychiatry. In: Mendlewicz J, Praag HM van (eds) Advances in biological Psychiatry, vol 6. Karger, Basel, pp 76–80

  33. Maxwell AE (1961) Analysing qualitative data. Methuen & Co., London

  34. May PRA, Putten T van, Yale C, Potepan P, Jenden DJ, Fairchild MD, Goldstein MJ (1976) Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 162:177–183

  35. Merrin EL, Fein G, Floyd TC, Yingling CD (1986) EEG asymmetry in schizophrenic patients before and during neuroleptic treatment. Biol Psychiatr 21:456–464

  36. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812

  37. Roth B (1961) The clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance. EEG Clin Neurophysiol 13:395–399

  38. Schneider J (1961) EEG and human psychopharmacology. Paper presented at 3rd World Congress of Psychiatry, Montreal

  39. Selbach H (1964) Principien der vegetativen Regulation als Vergleichsbasis für medikamentös bedingte Verhaltens-Änderungen an Tier und Mensch. In: Bradley PB, Flügel F, Hoch PH (eds) Neuro-psychopharmacology, vol 3. Elsevier, Amsterdam, pp 30–41

  40. Selbach H (1976) Das Kippschwingungsprinzip. In: Sturm A, Birkmayer W (eds) Klinische Pathologie des vegetativen Nervensystems, Bd I. G. Fischer, Stuttgart, pp 300–332

  41. Selbach C, Selbach H (1956) Phenothiazinwirkung und somato-psychische Dynamik. Nervenarzt 27:145–149

  42. Shagass Ch, Roemer RA, Straumanis JJ (1982) Relationships between psychiatric diagnosis and some quantitative EEG variables. Arch Gen Psychiatr 39:1423–1435

  43. Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatr 36:773–782

  44. Tucker DM (1983) Asymmetries of activation and arousal in psycho-pathology. In: Mendlewicz J, Praag HM van (eds) Advances in biological psychiatry, vol 13. Karger, Basel, pp 19–25

  45. Ulrich G, Frick K (1985) Asymmetry of occipital alpha-rhythm under resting conditions: a neurophysiological measure of “hemisphericity”. Percept Mot Skills 61:1323–1334

  46. Ulrich G, Frick K (1986) A new quantitiative approach to the assessment of stages of vigilance as defined by spatiotemporal EEG patterning. Percept Mot Skills 62:567–576

  47. Ulrich G, Renfordt E, Frick K (1986) Electroencephalographic dynamics of vigilance and drug-response in endogenous depression. A comparison of patients treated with amitriptyline or pirlindole. Pharmacopsychiatry 19 (1986) 270–271

  48. Ulrich G, Frick K, Stieglitz RD, Müller-Oerlinghausen B (1987) Interindividual variability of lithium-induced EEG changes in healthy volunteers. Psychiatry Res 20:117–127

  49. Wagner R (1954) Probleme und Beispiele biologischer Regelung. G. Thieme, Stuttgart

Download references

Author information

Correspondence to G. Ulrich.

Additional information

This investigation is dedicated to the late Prof. Dr. H. Selbach who followed its proceeding with vivid interest

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ulrich, G., Gaebel, W., Pietzcker, A. et al. Prediction of neuroleptic on-drug response in schizophrenic in-patients by EEG. Eur Arch Psychiatr Neurol Sci 237, 144–155 (1988). https://doi.org/10.1007/BF00451282

Download citation

Key words

  • EEG
  • Schizophrenia
  • Neuroleptic treatment